Q4 2016 Holdings
Filed 2017-02-14 | 11 holdings | $88.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Biogen Inc(BIIB) | COM | 09062X103 | $87.9M | 310,000 | 99.0% |
| Abbvie Inc.(ABBV) | COM | 00287Y109 | $626.0K | 10,000 | 0.7% |
| Ariad Pharmaceuticals Inc | COM | 04033A100 | $159.9K | 12,850,000 | 0.2% |
| Medicines Co | COM | 584688105 | $59.5K | 1,752,000 | 0.1% |
| Innoviva Inc(INVA) | COM | 45781M101 | $31.8K | 2,975,000 | 0.0% |
| Novelion Therapeutics Inc | COM NEW | 67001K202 | $8.6K | 1,025,000 | 0.0% |
| Intra Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $5.4K | 360,000 | 0.0% |
| Advaxis Inc | COM NEW | 007624208 | $3.6K | 500,000 | 0.0% |
| Vivus Inc | COM | 928551100 | $3.0K | 2,573,943 | 0.0% |
| Apricus Biosciences Inc | COM NEW | 03832V307 | $1.9K | 1,447,906 | 0.0% |
| Aveo Pharmaceuticals Inc(AVEOEUR) | COM | 053588109 | $917 | 1,700,000 | 0.0% |